Vanguard PRIMECAP Core Fund AZN Holdings History
Vanguard PRIMECAP Core Fund's AstraZeneca PLC Holding Summary
As of 2025-03-31, VANGUARD FENWAY FUNDS held 5.46 Mil shares of AstraZeneca PLC(AZN), totaling $401.43 Mil. This investment constitutes 3.53% of their stock portfolio, and VANGUARD FENWAY FUNDS now holds 0.18% of the outstanding AstraZeneca PLC(AZN) stock.
The initial trade took place in 2019Q3. And since then Vanguard PRIMECAP Core Fund has made 3 purchases of AZN, at an average price of $43.81, for a total of 7.04 Mil shares. In addition, there have been 15 sales at an average price of $55.87 for 1.58 Mil shares. Based on historical transaction data and AZN's current price of $69.26, Vanguard PRIMECAP Core Fund's estimated gain on his AZN holdings is $158.01 Mil, reflecting a 51.22% gain to date.
Vanguard PRIMECAP Core Fund AZN ($69.26) Holding Chart
Vanguard PRIMECAP Core Fund AZN ($69.26) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
